Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Basal cell carcinoma shows keratin patterns similar to undifferentiated hair follicle cells.

The tumor likely shows dual neural crest differentiation.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Stem cells play a key role in nonmelanoma skin cancers, with different origins and genetic changes linked to basal and squamous cell carcinomas.

Complex basal cell carcinomas need personalized treatment due to unique genetic mutations.

Human basal cell carcinomas and squamous cell carcinomas have unique gene expression patterns not fully mirrored in mouse models.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

CK 15, follistatin, and Bmi-1 can help differentiate basal cell carcinoma from squamous cell carcinoma.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Apocrine type cutaneous mixed tumors often resemble hair follicles, sebaceous glands, and apocrine glands.

Matrical tumors share a common growth mechanism involving the Wnt pathway and consistent PHLDA1 expression.

Trichoblastomas may mimic fetal skin development by having many Merkel cells, unlike adult skin.

Basal cell carcinoma is more common than squamous cell carcinoma on the scalp, especially along the part line.

Malignant melanoma is the deadliest skin cancer, while BCC is the most common but rarely spreads, and SCC is more aggressive than BCC.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

PTCH gene mutations contribute to basal cell carcinoma development.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Nine hair follicle tumors were found in dogs.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

A woman had a non-cancerous skin tumor on her eyelid removed successfully.

Melanocytic matricoma can look like skin cancer but is usually harmless; surgery and follow-up are advised.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.